KONINKLIJKE PHILIPS NV (1PHIA.MI) Stock Fundamental Analysis
BIT:1PHIA - Euronext Milan - NL0000009538 - Common Stock - Currency: EUR
Taking everything into account, 1PHIA scores 3 out of 10 in our fundamental rating. 1PHIA was compared to 55 industry peers in the Health Care Equipment & Supplies industry. 1PHIA may be in some trouble as it scores bad on both profitability and health. 1PHIA has a correct valuation and a medium growth rate.
1. Profitability
1.1 Basic Checks
1PHIA had positive earnings in the past year.
1PHIA had a positive operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: 1PHIA reported negative net income in multiple years.
1PHIA had a positive operating cash flow in 4 of the past 5 years.
1.2 Ratios
1PHIA has a Return On Assets of -2.42%. This is comparable to the rest of the industry: 1PHIA outperforms 45.45% of its industry peers.
1PHIA's Return On Equity of -5.85% is in line compared to the rest of the industry. 1PHIA outperforms 45.45% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -2.42% | ||
| ROE | -5.85% | ||
| ROIC | N/A |
ROA(3y)-3.08%
ROA(5y)1.15%
ROE(3y)-7.29%
ROE(5y)2.23%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
1PHIA's Operating Margin has declined in the last couple of years.
1PHIA has a worse Gross Margin (43.13%) than 65.45% of its industry peers.
In the last couple of years the Gross Margin of 1PHIA has remained more or less at the same level.
The Profit Margin and Operating Margin are not available for 1PHIA so they could not be analyzed.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 43.13% |
OM growth 3Y-2.25%
OM growth 5Y-8.45%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y4.71%
GM growth 5Y1.08%
2. Health
2.1 Basic Checks
1PHIA does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, 1PHIA has less shares outstanding
The number of shares outstanding for 1PHIA has been increased compared to 5 years ago.
1PHIA has a worse debt/assets ratio than last year.
2.2 Solvency
1PHIA has an Altman-Z score of 1.71. This is a bad value and indicates that 1PHIA is not financially healthy and even has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of 1.71, 1PHIA is in line with its industry, outperforming 50.91% of the companies in the same industry.
1PHIA has a debt to FCF ratio of 8.68. This is a slightly negative value and a sign of low solvency as 1PHIA would need 8.68 years to pay back of all of its debts.
1PHIA's Debt to FCF ratio of 8.68 is in line compared to the rest of the industry. 1PHIA outperforms 60.00% of its industry peers.
A Debt/Equity ratio of 0.59 indicates that 1PHIA is somewhat dependend on debt financing.
1PHIA has a Debt to Equity ratio of 0.59. This is in the lower half of the industry: 1PHIA underperforms 60.00% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.59 | ||
| Debt/FCF | 8.68 | ||
| Altman-Z | 1.71 |
ROIC/WACCN/A
WACC6.24%
2.3 Liquidity
A Current Ratio of 1.23 indicates that 1PHIA should not have too much problems paying its short term obligations.
With a Current ratio value of 1.23, 1PHIA is not doing good in the industry: 60.00% of the companies in the same industry are doing better.
A Quick Ratio of 0.84 indicates that 1PHIA may have some problems paying its short term obligations.
The Quick ratio of 1PHIA (0.84) is comparable to the rest of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.23 | ||
| Quick Ratio | 0.84 |
3. Growth
3.1 Past
1PHIA shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 12.37%, which is quite good.
Measured over the past years, 1PHIA shows a decrease in Earnings Per Share. The EPS has been decreasing by -7.07% on average per year.
1PHIA shows a decrease in Revenue. In the last year, the revenue decreased by -0.82%.
Measured over the past years, 1PHIA shows a small growth in Revenue. The Revenue has been growing by 1.00% on average per year.
EPS 1Y (TTM)12.37%
EPS 3Y-5.48%
EPS 5Y-7.07%
EPS Q2Q%26.36%
Revenue 1Y (TTM)-0.82%
Revenue growth 3Y1.65%
Revenue growth 5Y1%
Sales Q2Q%1.98%
3.2 Future
The Earnings Per Share is expected to grow by 15.81% on average over the next years. This is quite good.
Based on estimates for the next years, 1PHIA will show a small growth in Revenue. The Revenue will grow by 5.73% on average per year.
EPS Next Y11.88%
EPS Next 2Y13.66%
EPS Next 3Y13.18%
EPS Next 5Y15.81%
Revenue Next Year3.9%
Revenue Next 2Y4.18%
Revenue Next 3Y4.38%
Revenue Next 5Y5.73%
3.3 Evolution
The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
Based on the Price/Earnings ratio of 18.06, the valuation of 1PHIA can be described as rather expensive.
Based on the Price/Earnings ratio, 1PHIA is valued cheaply inside the industry as 85.45% of the companies are valued more expensively.
1PHIA is valuated rather cheaply when we compare the Price/Earnings ratio to 29.35, which is the current average of the S&P500 Index.
The Price/Forward Earnings ratio is 16.10, which indicates a correct valuation of 1PHIA.
74.55% of the companies in the same industry are more expensive than 1PHIA, based on the Price/Forward Earnings ratio.
The average S&P500 Price/Forward Earnings ratio is at 22.10. 1PHIA is valued slightly cheaper when compared to this.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 18.06 | ||
| Fwd PE | 16.1 |
4.2 Price Multiples
Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of 1PHIA is on the same level as its industry peers.
Based on the Price/Free Cash Flow ratio, 1PHIA is valued cheaper than 83.64% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 26.81 | ||
| EV/EBITDA | 20.87 |
4.3 Compensation for Growth
1PHIA's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
1PHIA's earnings are expected to grow with 13.18% in the coming years. This may justify a more expensive valuation.
PEG (NY)1.52
PEG (5Y)N/A
EPS Next 2Y13.66%
EPS Next 3Y13.18%
5. Dividend
5.1 Amount
1PHIA does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
BIT:1PHIA (3/5/2025, 7:00:00 PM)
25.1
-0.17 (-0.67%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners48.26%
Inst Owner ChangeN/A
Ins Owners0.06%
Ins Owner ChangeN/A
Market Cap23.59B
Analysts73.33
Price Target28.93 (15.26%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly Dividend0
Dividend Growth(5Y)-70.49%
DP-0.14%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-13.57%
Min EPS beat(2)-16.56%
Max EPS beat(2)-10.58%
EPS beat(4)0
Avg EPS beat(4)-11.81%
Min EPS beat(4)-16.56%
Max EPS beat(4)-6.96%
EPS beat(8)2
Avg EPS beat(8)0.96%
EPS beat(12)3
Avg EPS beat(12)3.42%
EPS beat(16)5
Avg EPS beat(16)1.26%
Revenue beat(2)0
Avg Revenue beat(2)-2.99%
Min Revenue beat(2)-5.22%
Max Revenue beat(2)-0.76%
Revenue beat(4)0
Avg Revenue beat(4)-2.85%
Min Revenue beat(4)-5.22%
Max Revenue beat(4)-0.76%
Revenue beat(8)1
Avg Revenue beat(8)-2.36%
Revenue beat(12)2
Avg Revenue beat(12)-1.5%
Revenue beat(16)2
Avg Revenue beat(16)-2.3%
PT rev (1m)-0.41%
PT rev (3m)-3.21%
EPS NQ rev (1m)0%
EPS NQ rev (3m)N/A
EPS NY rev (1m)0.81%
EPS NY rev (3m)-6.84%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-0.65%
Revenue NY rev (3m)-1.58%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 18.06 | ||
| Fwd PE | 16.1 | ||
| P/S | 1.31 | ||
| P/FCF | 26.81 | ||
| P/OCF | 15.16 | ||
| P/B | 1.97 | ||
| P/tB | N/A | ||
| EV/EBITDA | 20.87 |
EPS(TTM)1.39
EY5.54%
EPS(NY)1.56
Fwd EY6.21%
FCF(TTM)0.94
FCFY3.73%
OCF(TTM)1.66
OCFY6.6%
SpS19.17
BVpS12.77
TBVpS-1.45
PEG (NY)1.52
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -2.42% | ||
| ROE | -5.85% | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 43.13% | ||
| FCFM | 4.88% |
ROA(3y)-3.08%
ROA(5y)1.15%
ROE(3y)-7.29%
ROE(5y)2.23%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y-2.25%
OM growth 5Y-8.45%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y4.71%
GM growth 5Y1.08%
F-Score6
Asset Turnover0.62
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.59 | ||
| Debt/FCF | 8.68 | ||
| Debt/EBITDA | 5.15 | ||
| Cap/Depr | 48.63% | ||
| Cap/Sales | 3.75% | ||
| Interest Coverage | N/A | ||
| Cash Conversion | 112.67% | ||
| Profit Quality | N/A | ||
| Current Ratio | 1.23 | ||
| Quick Ratio | 0.84 | ||
| Altman-Z | 1.71 |
F-Score6
WACC6.24%
ROIC/WACCN/A
Cap/Depr(3y)50.01%
Cap/Depr(5y)53.78%
Cap/Sales(3y)3.94%
Cap/Sales(5y)4.29%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)12.37%
EPS 3Y-5.48%
EPS 5Y-7.07%
EPS Q2Q%26.36%
EPS Next Y11.88%
EPS Next 2Y13.66%
EPS Next 3Y13.18%
EPS Next 5Y15.81%
Revenue 1Y (TTM)-0.82%
Revenue growth 3Y1.65%
Revenue growth 5Y1%
Sales Q2Q%1.98%
Revenue Next Year3.9%
Revenue Next 2Y4.18%
Revenue Next 3Y4.38%
Revenue Next 5Y5.73%
EBIT growth 1Y91.51%
EBIT growth 3Y-0.63%
EBIT growth 5Y-7.54%
EBIT Next Year67.55%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-45.51%
FCF growth 3Y-40.93%
FCF growth 5Y-1.73%
OCF growth 1Y-31.12%
OCF growth 3Y-32.38%
OCF growth 5Y-4.03%